Mike Mussallem | Chairman & CEO |
Scott Ullem | CFO |
Vijay Kumar | Evercore ISI |
David Lewis | Morgan Stanley |
Bob Hopkins | Bank of America Merrill Lynch |
Lawrence Biegelsen | Wells Fargo |
Chris Pasquale | Guggenheim |
Robbie Marcus | J.P. Morgan |
Rick Wise | Stifel |
Joanne Wuensch | BMO Capital Markets |
Jason Mills | Canaccord Genuity |
Matt Taylor | UBS |
Josh Jennings | Cowen & Company |
Matt Miksic | Credit Suisse |
Bruce Nudell | SunTrust |
Danielle Antalffy | SVB Leerink |
Welcome, and thank you for joining us today.
Just after the close of regular trading Edwards Lifesciences, released its First Quarter 2019 Financial Results.
During today's call, management will discuss the results included in the press release and accompanying financial schedules. And then use the remaining time for Q&A.
Our presenters on today's call are Mike Mussallem, Chairman and CEO; and Scott Ullem, CFO.